FDA Approves COVID-19 Booster Dose to 16 and 17-Year-Olds

The U.S. Food and Drug Administration (FDA) extended the emergency use authorization (EAU) for Pfizer-BioNTech’s COVID-19 booster shots to include 16 and 17-year-olds. The agency’s decision came after evaluating the immune response data of about 200 individuals, ages 18-55. Since Pfizer’s vaccine has been available to everyone 16 and older for almost a year, the […]

The post FDA Approves COVID-19 Booster Dose to 16 and 17-Year-Olds appeared first on Guardian Liberty Voice.